Orchestra BioMed Holdings, Inc. (OBIO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 159.33M |
| Enterprise Value | 126.33M |
| P/E Ratio | -2.87 |
| PEG Ratio | -0.22 |
| Price/Sales Ratio | 7.47 |
| Price/Book Ratio | 3.07 |
| Enterprise/Revenue | 7.63 |
| Enterprise/EBITDA | -4.73 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -1.67 |
| Operating Margin | -1.68 |
AD
Management Effectiveness
| Return On Assets | -0.54 |
| Return On Equity | -1.38 |
Income Statement
| Revenue | 33.48M |
| Revenue/Share | 0.85 |
| Gross Profit | 33.29M |
| EBITDA | -51.23M |
| Net Income | -52.7M |
| Diluted EPS | -1.38 |
Balance Sheet
| Total Cash | 94.4M |
| Total Cash/Share | 2.46 |
| Total Debt | 33.64M |
| Total Debt/Equity | 0.66 |
| Current Ratio | 7.03 |
| Book Value Per Share | 1.33 |
Price History
| 52-Week Change | 31.61 |
| 52-Week High | 5.42 |
| 52-Week Low | 2.2 |
| Moving Average 50 Days | 4.05 |
| Moving Average 200 Days | 3.97 |
Statistics
| Average Volume | 214,214 |
| Shares Outstanding | 59.88M |
| % Held by Institutions | 60.15 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
